860535
Last Update Posted: 2015-09-30
Recruiting has ended
All Genders accepted | 18 Years + |
9 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
Growth Factor Signature (GFS) Pilot Study (MK0000-098)(COMPLETED)
This study will evaluate a gene expression signature (Growth Factor Signature [GFS]) as a biomarker for response/resistance to BRC-ABL oncogene inhibitors.
Eligibility
Relevant conditions:
Blast Phase Philadelphia Chromosomes Positive (Ph+) Chronic Myelogenous Leukemia (CML)
Philadelphia Chromosome Positive (Ph+) Acute Lymphocytic Leukemia (ALL)
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.
locations
Contact Information
Overall Contact
No valid contacts available
Data sourced from ClinicalTrials.gov